EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors of distant metastatic recurrence in intermediate‐risk papillary thyroid carcinoma

Naoyoshi Onoda iD, Yasuhiro Ito iD, Akihiro Miya, Minoru Kihara, Akira Miyauchi

World Journal of Surgery · 2025

DOI: 10.1002/wjs.12289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, 2025. Verfasst von Naoyoshi Onoda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kuma Hospital, Kobe, Japan. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Thyroidectomy, Neoplasm Recurrence, Local. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with intermediate‐risk papillary thyroid carcinoma (PTC) have a favorable prognosis with standard treatment of total thyroidectomy (TT) and adjuvant radioactive iodine therapy (RAIT). However, the benefits of TT or adjuvant RAIT remain undetermined, and they are often omitted in Japan. We investigated risk factors for life‐threatening distant recurrence in patients with intermediate‐risk PTC who are optimal candidates for adjuvant RAIT. Patients and Methods Outcomes without RAIT were retrospectively examined in 4030 intermediate‐risk conventional PTC cases underwent initial surgery from 2005 to 22 (IRB approval 20200709‐1).

Results

Lobectomy (LT) and TT was performed in 11.5% and 88.5%, respectively. Recurrent laryngeal nerve paralysis and hypoparathyroidism was less commonly observed in LT (1.3% and 0%) than TT (2.4% and 3.5 %). Fifty‐six cases (1.4%) had distant recurrence. Recurrence‐free survival rates at 10 years was 93.5%. There was no significant difference in recurrence rate between LT and TT. Age ≥55, cN1b, and tumor diameter >30 mm significantly associated with distant recurrence. There was a strong relationship between the number of positive risk factors and recurrence; the distant recurrence rate in cases of 0, 1, 2, and 3 positive factors was 0.3% (4/1203), 1.3% (25/1889), 2.7% (23/830) and 7.1% (4/52) (HR 6.46 (2.34–17.86), Log‐rank 30 mm, adjuvant RAIT was considered eligible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid Cancer, PapillaryThyroidectomyNeoplasm Recurrence, LocalHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedRisk FactorsPrognosisRadiotherapy, AdjuvantYoung AdultJapanIodine RadioisotopesAdolescentAged, 80 and over

Stichwörter der Autor:innen

distant metastasisintermediate‐risk papillary thyroid carcinomapredictors

Substanzen

Iodine Radioisotopes

Autor:innen und Institutionen

  • Department of Surgery, Kuma Hospital, Kobe, Japan.

ORCID-Profile: Naoyoshi Onoda, Yasuhiro Ito

Zitieren

APA

Onoda, N., Ito, Y., Miya, A., Kihara, M., & Miyauchi, A. (2025). Predictors of distant metastatic recurrence in intermediate‐risk papillary thyroid carcinoma. World Journal of Surgery. https://doi.org/10.1002/wjs.12289

Vancouver

Onoda N, Ito Y, Miya A, Kihara M, Miyauchi A. Predictors of distant metastatic recurrence in intermediate‐risk papillary thyroid carcinoma. World Journal of Surgery. 2025. doi:10.1002/wjs.12289

BibTeX
@article{Onoda2025,
  author = {Onoda, Naoyoshi and Ito, Yasuhiro and Miya, Akihiro and Kihara, Minoru and Miyauchi, Akira},
  title = {Predictors of distant metastatic recurrence in intermediate‐risk papillary thyroid carcinoma},
  journal = {World Journal of Surgery},
  year = {2025},
  doi = {10.1002/wjs.12289}
}
Kostenlos starten →